HomeRAPT • NASDAQ
Rapt Therapeutics Inc
add
$0.81
7.82%
After Hours:(4.99%)-0.040
$0.77
Closed: May 15, 5:20:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.27M | -40.76% |
Net income | -17.17M | 43.76% |
Net profit margin | — | — |
Earnings per share | -0.08 | 89.87% |
EBITDA | -19.01M | 40.96% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 179.28M | 26.63% |
Total assets | 187.57M | 20.38% |
Total liabilities | 10.20M | -59.18% |
Total equity | 177.37M | — |
Shares outstanding | 132.29M | — |
Price to book | 0.56 | — |
Return on assets | -22.51% | — |
Return on capital | -25.65% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -17.17M | 43.76% |
Cash from operations | -52.41M | -93.52% |
Cash from investing | -57.06M | -459.19% |
Cash from financing | — | — |
Net change in cash | -109.48M | -4,966.08% |
Free cash flow | -46.49M | -140.80% |
Previous close
$0.75
Day range
$0.71 - $0.81
Year range
$0.71 - $4.83
Market cap
107.04M USD
Avg Volume
843.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
67
